IL200483A0 - Amelioration of cellular stress response - Google Patents

Amelioration of cellular stress response

Info

Publication number
IL200483A0
IL200483A0 IL200483A IL20048309A IL200483A0 IL 200483 A0 IL200483 A0 IL 200483A0 IL 200483 A IL200483 A IL 200483A IL 20048309 A IL20048309 A IL 20048309A IL 200483 A0 IL200483 A0 IL 200483A0
Authority
IL
Israel
Prior art keywords
amelioration
stress response
cellular stress
cellular
response
Prior art date
Application number
IL200483A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL200483A0 publication Critical patent/IL200483A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL200483A 2007-03-02 2009-08-19 Amelioration of cellular stress response IL200483A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89280607P 2007-03-02 2007-03-02
PCT/US2008/055714 WO2008109560A2 (fr) 2007-03-02 2008-03-03 Amélioration de la réponse au stress cellulaire

Publications (1)

Publication Number Publication Date
IL200483A0 true IL200483A0 (en) 2010-04-29

Family

ID=39532129

Family Applications (1)

Application Number Title Priority Date Filing Date
IL200483A IL200483A0 (en) 2007-03-02 2009-08-19 Amelioration of cellular stress response

Country Status (8)

Country Link
EP (1) EP2118133A2 (fr)
JP (1) JP2010521425A (fr)
CN (1) CN101790539A (fr)
AU (1) AU2008222926A1 (fr)
CA (1) CA2678555A1 (fr)
IL (1) IL200483A0 (fr)
MX (1) MX2009009197A (fr)
WO (1) WO2008109560A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010279384A1 (en) * 2009-08-05 2012-03-01 Wake Forest University Compositions and methods for inducing apoptosis in prostate cancer cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790631B1 (en) * 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof

Also Published As

Publication number Publication date
EP2118133A2 (fr) 2009-11-18
MX2009009197A (es) 2009-09-04
CA2678555A1 (fr) 2008-09-12
WO2008109560A2 (fr) 2008-09-12
CN101790539A (zh) 2010-07-28
AU2008222926A1 (en) 2008-09-12
WO2008109560A3 (fr) 2008-12-11
JP2010521425A (ja) 2010-06-24

Similar Documents

Publication Publication Date Title
GB2446847B (en) Location of Basestation
AP2999A (en) Support of UICC-less calls
EP2231168A4 (fr) Nouvelles structures d'arnsi
EP2122695A4 (fr) Réseau d'éléments luminescents
EP2118660A4 (fr) Tri de micro-dispositifs
PL3729998T3 (pl) Złożony element zawierający dwa elementy panelowe
EP2150877A4 (fr) Activation sélective de commandes multi-entrée
GB0815216D0 (en) Interleukin
DK2181057T3 (da) Fremgangsmåder til at isolere tilstødende artikler
ZA201102604B (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
PL2133419T3 (pl) Zastosowania beta-dipeptydów cyjanoficyny
GB0804487D0 (en) Cellular structures
GB2455188B (en) Structure of dual symmetrical antennas
ZA201006228B (en) Combined use of cholestanol derivative
IL200483A0 (en) Amelioration of cellular stress response
GB2480406B (en) Location of basestation
EP2100345A4 (fr) Antenne de type annulaire parallèle
PL383760A1 (pl) Nowe zastosowanie undekan-2-olu
PL383758A1 (pl) Nowe zastosowanie undekan-2-onu
PL383759A1 (pl) Nowe zastosowanie undekan-2-olu
AU2009100669A4 (en) Supa Staka
GB0705204D0 (en) Uses of (S)-clenbuterol
PL384163A1 (pl) Mikrokapsułki chlomazonu
TWM311768U (en) Improved structure of A-ladder
GB0805096D0 (en) Cellular balloon